MARK CHAPLICK: Open Payments
NPI 1316928179 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 19 payments from 13 companies in 2025. Trend: 2023 $570 · 2024 $547 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 4 | $167 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| ANI Pharmaceuticals, Inc. | 2 | $35 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| TerSera Therapeutics LLC | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
| BIOTRONIK NRO, Inc. | 1 | $20 |
| Fidia Pharma USA Inc. | 1 | $18 |
| Forte Bio-Pharma LLC | 1 | $16 |
Products named: Senza, Vyrsa V1, PURIFIED CORTROPHIN GEL, XTAMPZA, JOURNAVX, Prialt, RELISTOR, INCEPTIV.
Industry payments across MO — which companies pay providers there.
